Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients.

Analytical cellular pathology (Amsterdam) - 1 Jan 2010

Fariña-Sarasqueta A, Gosens M J E M, Moerland E, van Lijnschoten I, Lemmens V E P P, Slooter G D, Rutten H J T, van den Brule A J C

Abstract excerpt

AIM: Although the predictive and prognostic value of thymidylate synthase (TS) expression and gene polymorphism in colon cancer has been widely studied, the results are inconclusive probably because of methodological differences. With this study, we aimed to elucidate the role of TS gene polymorp...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Colonic Neoplasms
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorouracil

Share to Kaplan-Meier Estimate

Share to Neoplasm Staging

Share to Tandem Repeat Sequences

Share to Thymidylate Synthase

Source

Open in PubMed Open full text

Identifiers

PMID: 20966539
DOI: 10.3233/ACP-CLO-2010-0526
PMCID: PMC4605551

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20966539-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients.PMID 20966539Read ↗

TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients.Semantic proximity Read ↗

Relationship of polymorphism of the tandem repeat sequence in the thymidylate synthase gene and the survival of stage III colorectal cancer patients receiving adjuvant 5-flurouracil-based chemotherapy.Semantic proximity Read ↗

Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer.Semantic proximity Read ↗

Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil.Semantic proximity Read ↗

Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study.Semantic proximity Read ↗

Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?Semantic proximity Read ↗

Thymidylate synthase genotyping is more predictive for therapy response than immunohistochemistry in patients with colon cancer.Semantic proximity Read ↗

Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.Semantic proximity Read ↗

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.Semantic proximity Read ↗

Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.Semantic proximity Read ↗

G>C SNP of thymidylate synthase with respect to colorectal cancer.Semantic proximity Read ↗

Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.